Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

EG 626

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
7-Ethoxycarbonyl-4-hydroxymethyl-6,8-dimethyl-1(2H)-phthalazinone (EG 626) (0.3-3 mg/kg i.v.), a new cyclic AMP phosphodiesterase… Expand
1980
1980
Effects of Phthalazinol (EG 626), a cyclic AMP phosphodiesterase inhibitor, a thromboxane A2 antagonist and an… Expand
1980
1980
To enhance the biostability of the ester linkage of 7-ethoxycarbonyl-4-hydroxymethyl-1(2H)-phthalazinone, which has potent… Expand
1979
1979
Effects of phthalazinol, EG 626, on the membrane and mechanical properties of the vascular smooth muscles, namely superior… Expand
1979
1979
Phthalazinol (EG 626), a thromboxane A2 antagonist and cyclic AMP phosphodiesterase inhibitor, has been shown to prevent the… Expand
1977
1977
Sticking and aggregation of platelets to the damaged or denuded endothelial surface of atheromatous plaque are common findings in… Expand